摘要
目的:分析急性肺栓塞的临床特点,观察溶栓、抗凝治疗对急性肺栓塞的临床治疗效果。方法:21例肺栓塞患者根据临床症状、体格检查、实验室检查、超声检查及肺动脉造影确诊。21例患者均行肺动脉造影确诊,对其中不属溶栓适应症的8例给予肝素抗凝治疗,属溶栓适应症的9例行静脉溶栓加抗凝治疗,对其中血液动力学差的中/大块肺栓塞4例行肺动脉内导管碎栓、吸栓加肺动脉内尿激酶溶栓再加术后抗凝治疗。以临床、化验室检查及超声心动图及肺动脉造影评价治疗效果。结果:院外误诊率高达77.8%,尿激酶溶栓加抗凝治疗组13例,总有效率为63.2%。根据本组有限病例观察溶栓效果与栓塞面积未见差异,而与发病开始到溶栓治疗的时间密切相关(P<0.05)。肝素抗凝8例,1例无效。结论:应提高肺动脉栓塞的警惕性,减少误诊率。尿激酶对急性大块肺栓塞溶栓抗凝治疗安全有效,溶栓时间窗越靠前疗效越好;对有溶栓适应症的患者应首选溶栓治疗。
Objective: To evaluate the efficacy of thromblytic therapy with urokinase ( UK ) and antico- agulation therapy with heparin, and analyze the clinical characteristics of pulmonary embolism . Methods: The diagnosis of pulmonary embolism was based on the results of perfusion lung scanning , selective pulmonary arteriography or ultrasound cardiogram. Thirteen patients wrer treated by thrombolytic therapy, and eight by anticoagulant therapy. Results: Misdiagnostic rate before hospital admission was 77.8%. Thirteen patients with pulmonary embolism were treated by UK. The effective rate was 63.2%. The area of embolism was not related to the effectiveness of thrombolytic therapy, but the time starting the therapy was closely related to efficacy ( P = 0.03 ). eight patients were treated by heparin , of who hepatin was effective in one. Conclusion: It is effective and safe to administer UK intravenously in patients with acute pulmonary embolism. Thromboiytic therapy is the first choice, the earlier the better.
出处
《河北医学》
CAS
2008年第8期926-928,共3页
Hebei Medicine
关键词
肺栓塞
血栓溶栓疗法
尿激素
Pulmonary embolism
Thrombolytic therapy
Urokinase